Effects of intravenous infusion of autogenous ascitic fluid and tolbutamide therapy on protein and electrolyte metabolism in decompensated cirrhosis of the liver.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001202:Ascitic Fluid; D001798:Blood Proteins; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000378:metabolism*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011506:Proteins / Q000378:metabolism*; D014044:Tolbutamide / Q000627:therapeutic use*; D014882:Water-Electrolyte Balance
D001798:Blood Proteins; D011506:Proteins; D014044:Tolbutamide